The current conclusion of the review is that child‐feeding practices may increase fruit and vegetable intake by children, but this conclusion is based on low‐quality evidence and the authors' confidence in this effect is limited.
Saturated Fat Review Update Receives Attention
In May we also published an update exploring the effect of diet on cardiovascular items, which was featured in a Cochrane news item. The update 'Reduction in saturated fat intake for cardiovascular disease' investigated whether if following the guidelines on reducing saturated fat had any outcome on the risk of dying or getting cardiovascular disease (heart disease or stroke). The study concluded that if 56 people without cardiovascular disease, or 32 people who already have cardiovascular disease, reduce their saturated fat for around four years, then one person will avoid a cardiovascular event (heart attack or stroke) that they would otherwise have experienced.
Interested in writing a Cochrane review and an expert in cardiology? - Consider these vacant titles:
Proposals closing on 30 June 2020:
Association of aspirin and Anticoagulants for primary prevention of cardiovascular disease (new title)
Remote monitoring of Implantable Cardiac Defibrillators for prevention of cardiovascular outcomes (new title)
Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement (new title)
Alcohol consumption and cardiovascular disease (new title)
Proposal closing on 31 August 2020:
Colchicine for the primary prevention of cardiovascular events (supersedes our existing review that is split into two new reviews, one for primary prevention and one for secondary prevention)
mHealth education interventions in heart failure (review)
Coronary artery bypass surgery versus medical therapy alone for Ischaemic heart disease (protocol)
Different rate-controlling agents for the management of atrial fibrillation with rapid ventricular rate in the emergency department: a network meta-analysis (protocol)
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis (protocol)
